Literature DB >> 10203040

Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART).

M L Gougeon1, H Lecoeur, Y Sasaki.   

Abstract

Apoptosis markers and the rate of lymphocyte apoptosis were followed in the peripheral blood of HIV infected persons at various stages of disease. Our study suggests that the early increase in memory cells following therapy may also be due to a significant decrease in apoptosis in this subset. The intrinsic resistance to apoptosis in the naive subset appears to be maintained following HIV infection and is not modified following highly active anti-retroviral treatment (HAART).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203040     DOI: 10.1016/s0165-2478(98)00167-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.

Authors:  Y Sasaki; Y Ami; T Nakasone; K Shinohara; E Takahashi; S Ando; K Someya; Y Suzaki; M Honda
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents.

Authors:  Maristela Miyamoto; Silvana D Pessoa; Erika Ono; Daisy M Machado; Reinaldo Salomão; Regina C de M Succi; Savita Pahwa; Maria Isabel de Moraes-Pinto
Journal:  J Trop Pediatr       Date:  2010-04-13       Impact factor: 1.165

Review 3.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

4.  Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration. Irhan Study Group.

Authors:  A Amendola; F Poccia; F Martini; C Gioia; V Galati; M Pierdominici; M Marziali; F Pandolfi; V Colizzi; M Piacentini; E Girardi; G D'offizi
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

5.  Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.

Authors:  C Pratesi; C Simonelli; S Zanussi; R Talamini; M T Bortolin; R Tedeschi; A Marus; C Caffau; M Michieli; U Tirelli; P De Paoli
Journal:  Clin Exp Immunol       Date:  2007-10-11       Impact factor: 4.330

6.  Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy.

Authors:  Christos Tsoukas; Louise Gilbert; Trevor Lewis; George Hatzakis; Ron Falcon; Joseph Mrus
Journal:  ISRN AIDS       Date:  2013-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.